Endophthalmitis

Cataracts are the leading cause of blindness in adults older than age 50 worldwide.

Cataract surgery in small hyperopic eyes can be challenging due to the constraints of working in a significantly smaller space.

KOLOA, Hawaii — Retina specialists have a lot of options when it comes to intravitreal injection procedures, according to a speaker at Retina 2025.

KOLOA, Hawaii — Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here.

KOLOA, Hawaii — Office-based surgery is safe and can help ophthalmology practices generate more revenue, according to a speaker at Hawaiian Eye 2025.

Laru-zova demonstrated a positive safety profile and early efficacy in improving low luminance visual acuity in patients with X-linked retinitis pigmentosa, according to a presentation at the FLORetina-ICOOR meeting.

There are two lines of research we are pursuing in our lab currently.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

BARCELONA, Spain — A large amount of real-world data collected from clinics across the U.K. highlighted the effectiveness, safety and durability of faricimab for diabetic macular edema in treatment-naive and previously treated eyes.

A phase 2b clinical trial of CLS-AX, a tyrosine kinase inhibitor under evaluation for the treatment of wet age-related macular degeneration, achieved its primary and secondary outcomes, according to a Clearside Biomedical press release.